A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone

Henry Lik‐Yuen Chan, Nancy Leung, Alex Hui, Vincent Wai‐Sun Wong, Choong-Tsek Liew, Angel Mei–Ling Chim, Francis K.l. Chan, Lawrence Cheung–Tsui Hung, Yuk-Tong Lee, John S. Tam, Christopher Wai-Kei Lam, Joseph J.�y. SungAnnals 2005 · DOI

Abstract

In patients with HBeAg-positive chronic hepatitis B, staggered combination treatment with pegylated interferon-alpha2b and lamivudine may lead to a higher rate of virologic response than lamivudine monotherapy.
BibTeX
@article{chan2005randomized,
  author = {Henry Lik‐Yuen Chan and Nancy Leung and Alex Hui and Vincent Wai‐Sun Wong and Choong-Tsek Liew and Angel Mei–Ling Chim and Francis K.L. Chan and Lawrence Cheung–Tsui Hung and Yuk-Tong Lee and John S. Tam and Christopher Wai-Kei Lam and Joseph J.�Y. Sung},
  title = {{A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone}},
  journal = {Annals},
  year = {2005},
  doi = {10.7326/0003-4819-142-4-200502150-00006},
}

Loading related content...

Figure